Evaluating endocrine disrupting chemicals: A perspective on the novel assessments in CLARITY-BPA.
Birth Defects Res
; 115(15): 1345-1397, 2023 09 01.
Article
in En
| MEDLINE
| ID: mdl-37646438
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Endocrine Disruptors
Type of study:
Guideline
/
Prognostic_studies
Limits:
Female
/
Humans
/
Male
Language:
En
Journal:
Birth Defects Res
Year:
2023
Type:
Article
Affiliation country:
United States